Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes

Genome Research

Volumn 17, Issue 6, 2007, Pages 708-719

  Rada Iglesias, Alvaro ^a   Enroth, Stefan ^b   Ameur, Adam ^b   Koch, Christoph M ^c   Clelland, Gayle K ^c   Respuela Alonso, Patricia ^a   Wilcox, Sarah ^c   Dovey, Oliver M ^c   Ellis, Peter D ^c   Langford, Cordelia F ^c   Dunham, Ian ^c   Komorowski, Jan ^b   Wadelius, Claes ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; RNA POLYMERASE II; TRICHOSTATIN A;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL NUCLEUS; CELL STRAIN HT29; COLON ADENOCARCINOMA; DEACETYLATION; DNA BINDING; DNA MICROARRAY; DOWN REGULATION; EUCHROMATIN; GENE FUNCTION; GENE REPRESSION; GENE STRUCTURE; GENOME; HUMAN; HUMAN CELL; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION SITE;

ACETYLATION; ADENOCARCINOMA; BUTYRATES; CELL LINE, TUMOR; COLONIC NEOPLASMS; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HISTONES; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 34250326306     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.5540007     Document Type: Article

References (65)

1. Ameur, A., Yankovski, V., Enroth, S., Spjuth, O., and Komorowski, J. 2006. The LCB DataWareHouse. Bioinformatics 22: 1024-1026.
2. Andrulis, E.D., Neiman, A.M., Zappulla, D.C., and Sternglanz, R. 1998. Perinuclear localization of chromatin facilitates transcriptional silencing. Nature 394: 592-595.
3. Balciunaite, E., Spektor, A., Lents, N.H., Cam, H., Te Riele, H., Scime, A., Rudnicki, M.A., Young, R., and Dynlacht, B.D. 2005. Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol. Cell. Biol. 25: 8166-8178.
4. Bartova, E., Pachernik, J., Harnicarova, A., Kovarik, A., Kovarikova, M., Hofmanova, J., Skalnikova, M., Kozubek, M., and Kozubek, S. 2005. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. J. Cell Sci. 118: 5035-5046.
5. Baylin, S.B. 2005. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. (Suppl. 1) 2: S4-11.
6. Bernstein, B.E., Kamal, M., Lindblad-Toh, K., Bekiranov, S., Bailey, D.K., Huebert, D.J., McMahon, S., Karlsson, E.K., Kulbokas 3rd, E.J., Gingeras, T.R., et al. 2005. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120: 169-181.
7. Daly, K. and Shirazi-Beechey, S.P. 2006. Microarray analysis of butyrate regulated genes in colonic epithelial cells. DNA Cell Biol. 25: 49-62.
8. Dashwood, R.H., Myzak, M.C., and Ho, E. 2006. Dietary HDAC inhibitors: Time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 27: 344-349.
9. Davie, J.R. 2003. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133: 2485S-2493S.
10. Dehm, S.M., Hilton, T.L., Wang, E.H., and Bonham, K. 2004. SRC proximal and core promoter elements dictate TAF1 dependence and transcriptional repression by histone deacetylase inhibitors. Mol. Cell. Biol. 24: 2296-2307.
11. de Ruijter, A.J., Meinsma, R.J., Bosma, P., Kemp, S., Caron, H.N., and van Kuilenburg, A.B. 2005. Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma. Exp. Cell Res. 309: 451-467.
12. Dimitri, P., Corradini, N., Rossi, F., and Verni, F. 2005. The paradox of functional heterochromatin. Bioessays 27: 29-41.
13. Donadel, G., Garzelli, C., Frank, R., and Gabrielli, F. 1991. Identification of a novel nuclear protein synthesized in growth-arrested human hepatoblastoma HepG2 cells. Eur. J. Biochem. 195: 723-729.
14. Dou, Y., Milne, T.A., Tackett, A.J., Smith, E.R., Fukuda, A., Wysocka, J., Allis, C.D., Chait, B.T., Hess, J.L., and Roeder, R.G. 2005. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 121: 873-885.
15. Duan, H., Heckman, C.A., and Boxer, L.M. 2005. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol. Cell. Biol. 25: 1608-1619.
16. Dunphy, E.L., Johnson, T., Auerbach, S.S., and Wang, E.H. 2000. Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression. Mol. Cell. Biol. 20: 1134-1139.
17. Emanuele, S., D'Anneo, A., Bellavia, G., Vassallo, B., Lauricella, M., De Blasio, A., Vento, R., and Tesoriere, G. 2004. Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of β-catenin, pRb and Bcl-XL. Eur. J. Cancer 40: 1441-1452.
18. The ENCODE Project Consortium. 2004. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306: 636-640.
19. Fraga, M.F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. 2005. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat. Genet. 37: 391-400.
20. Gialitakis, M., Kretsovali, A., Spilianakis, C., Kravariti, L., Mages, J., Hoffmann, R., Hatzopoulos, A.K., and Papamatheakis, J. 2006. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A. Nucleic Acids Res. 34: 765-772.
21. Goncalves, J., Malta-Vacas, J., Louis, M., Brault, L., Bagrel, D., Monteiro, C., and Brito, M. 2005. Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells. Clin. Chem. Lab. Med. 43: 151-156.
22. Han, J.W., Ahn, S.H., Kim, Y.K., Bae, G.U., Yoon, J.W., Hong, S., Lee, H.Y., Lee, Y.W., and Lee, H.W. 2001. Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: Involvement of protein kinase C. J. Biol. Chem. 276: 42084-42090.
23. Hazzalin, C.A. and Mahadevan, L.C. 2005. Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: Analysis at c-fos and c-jun. PLoS Biol. 3: e393.
24. Heruth, D.P., Zirnstein, G.W., Bradley, J.F., and Rothberg, P.G. 1993. Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J. Biol. Chem. 268: 20466-20472.
25. Hirsch, C.L. and Bonham, K. 2004. Histone deacetylase inhibitors regulate p21WAF1 gene expression at the post-transcriptional level in HepG2 cells. FEBS Lett. 570: 37-40.
26. Jackson, J.G. and Pereira-Smith, O.M. 2006. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol. Cell. Biol. 26: 2501-2510.
27. Jones, P.A. and Baylin, S.B. 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3: 415-428.
28. Kim, E.H., Kim, H.S., Kim, S.U., Noh, E.J., Lee, J.S., and Choi, K.S. 2005a. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Oncogene 24: 6877-6889.
29. Kim, T.H., Barrera, L.O., Zheng, M., Qu, C., Singer, M.A., Richmond, T.A., Wu, Y., Green, R.D., and Ren, B. 2005b. A high-resolution map of active promoters in the human genome. Nature 436: 876-880.
30. Kostyniuk, C.L., Dehm, S.M., Batten, D., and Bonham, K. 2002. The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylases. Oncogene 21: 6340-6347.
31. Kristjuhan, A. and Svejstrup, J.Q. 2004. Evidence for distinct mechanisms facilitating transcript elongation through chromatin in vivo. EMBO J. 23: 4243-4252.
32. Lallemand, F., Courilleau, D., Sabbah, M., Redeuilh, G., and Mester, J. 1996. Direct inhibition of the expression of cyclin D1 gene by sodium butyrate. Biochem. Biophys. Res. Commun. 229: 163-169.
33. Lee, C.K., Shibata, Y., Rao, B., Strahl, B.D., and Lieb, J.D. 2004. Evidence for nucleosome depletion at active regulatory regions genome-wide. Nat. Genet. 36: 900-905.
34. Lieb, J.D. and Clarke, N.D. 2005. Control of transcription through intragenic patterns of nucleosome composition. Cell 123: 1187-1190.
35. Lindemann, R.K., Gabrielli, B., and Johnstone, R.W. 2004. Histone-deacetylase inhibitors for the treatment of cancer. Cell Cycle 3: 779-788.
36. Maison, C., Bailly, D., Peters, A.H., Quivy, J.P., Roche, D., Taddei, A., Lachner, M., Jenuwein, T., and Almouzni, G. 2002. Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat. Genet. 30: 329-334.
37. Mizzen, C.A., Yang, X.J., Kokubo, T., Brownell, J.E., Bannister, A.J., Owen-Hughes, T., Workman, J., Wang, L., Berger, S.L., Kouzarides, T., et al. 1996. The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell 87: 1261-1270.
38. Murray, J.I., Whitfield, M.L., Trinklein, N.D., Myers, R.M., Brown, P.O., and Botstein, D. 2004. Diverse and specific gene expression responses to stresses in cultured human cells. Mol. Biol. Cell 15: 2361-2374.
39. O'Brien, T. and Tjian, R. 2000. Different functional domains of TAFII250 modulate expression of distinct subsets of mammalian genes. Proc. Natl. Acad. Sci. 97: 2456-2461.
40. Peart, M.J., Smyth, G.K., van Laar, R.K., Bowtell, D.D., Richon, V.M., Marks, P.A., Holloway, A.J., and Johnstone, R.W. 2005. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc. Natl. Acad. Sci. 102: 3697-3702.
41. Piluso, D., Bilan, P., and Capone, J.P. 2002. Host cell factor-1 interacts with and antagonizes transactivation by the cell cycle regulatory factor Miz-1. J. Biol. Chem. 277: 46799-46808.
42. Pokholok, D.K., Harbison, C.T., Levine, S., Cole, M., Hannett, N.M., Lee, T.I., Bell, G.W., Walker, K., Rolfe, P.A., Herbolsheimer, E., et al. 2005. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122: 517-527.
43. Polioudaki, H., Kourmouli, N., Drosou, V., Bakou, A., Theodoropoulos, P.A., Singh, P.B., Giannakouros, T., and Georgatos, S.D. 2001. Histones H3/H4 form a tight complex with the inner nuclear membrane protein LBR and heterochromatin protein 1. EMBO Rep. 2: 920-925.
44. Pray-Grant, M.G., Daniel, J.A., Schieltz, D., Yates 3rd, J.R., and Grant, P.A. 2005. Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature 433: 434-438.
45. Rada-Iglesias, A., Wallerman, O., Koch, C., Ameur, A., Enroth, S., Clelland, G., Wester, K., Wilcox, S., Dovey, O.M., Ellis, P.D., et al. 2005. Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. Hum. Mol. Genet. 14: 3435-3447.
46. Rayman, J.B., Takahashi, Y., Indjeian, V.B., Dannenberg, J.H., Catchpole, S., Watson, R.J., te Riele, H., and Dynlacht, B.D. 2002. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes & Dev. 16: 933-947.
47. Reid, G., Metivier, R., Lin, C.Y., Denger, S., Ibberson, D., Ivacevic, T., Brand, H., Benes, V., Liu, E.T., and Gannon, F. 2005. Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor α, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene 24: 4894-4907.
48. Richon, V.M., Sandhoff, T.W., Rifkind, R.A., and Marks, P.A. 2000. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc. Natl. Acad. Sci. 97: 10014-10019.
49. Ruemmele, F.M., Schwartz, S., Seidman, E.G., Dionne, S., Levy, E., and Lentze, M.J. 2003. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 52: 94-100.
50. Sadoni, N., Langer, S., Fauth, C., Bernardi, G., Cremer, T., Turner, B.M., and Zink, D. 1999. Nuclear organization of mammalian genomes. Polar chromosome territories build up functionally distinct higher order compartments. J. Cell Biol. 146: 1211-1226.
51. Schubeler, D., MacAlpine, D.M., Scalzo, D., Wirbelauer, C., Kooperberg, C., van Leeuwen, F., Gottschling, D.E., O'Neill, L.P., Turner, B.M., Delrow, J., et al. 2004. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes & Dev. 18: 1263-1271.
52. Scott, G.K., Mattie, M.D., Berger, C.E., Benz, S.C., and Benz, C.C. 2006. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 66: 1277-1281.
53. Smale, S.T. and Kadonaga, J.T. 2003. The RNA polymerase II core promoter. Annu. Rev. Biochem. 72: 449-479.
54. Somech, R., Shaklai, S., Geller, O., Amariglio, N., Simon, A.J., Rechavi, G., and Gal-Yam, E.N. 2005. The nuclear-envelope protein and transcriptional repressor LAP2β interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. J. Cell Sci. 118: 4017-4025.
55. Soutoglou, E., Katrakili, N., and Talianidis, I. 2000. Acetylation regulates transcription factor activity at multiple levels. Mol. Cell 5: 745-751.
56. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes & Dev. 12: 599-606.
57. Suzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M.P., Herman, J.G., and Baylin, S.B. 2002. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31: 141-149.
58. Taddei, A., Maison, C., Roche, D., and Almouzni, G. 2001. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat. Cell Biol. 3: 114-120.
59. Taddei, A., Roche, D., Bickmore, W.A., and Almouzni, G. 2005. The effects of histone deacetylase inhibitors on heterochromatin: Implications for anticancer therapy? EMBO Rep. 6: 520-524.
60. Tong, X., Yin, L., Joshi, S., Rosenberg, D.W., and Giardina, C. 2005. Cyclooxygenase-2 regulation in colon cancer cells: Modulation of RNA polymerase II elongation by histone deacetylase inhibitors. J. Biol. Chem. 280: 15503-15509.
61. Villar-Garea, A. and Esteller, M. 2004. Histone deacetylase inhibitors: Understanding a new wave of anticancer agents. Int. J. Cancer 112: 171-178.
62. Wanzel, M., Kleine-Kohlbrecher, D., Herold, S., Hock, A., Berns, K., Park, J., Hemmings, B., and Eilers, M. 2005. Akt and 14-3-3η regulate Miz1 to control cell-cycle arrest after DNA damage. Nat. Cell Biol. 7: 30-41.
63. Weierich, C., Brero, A., Stein, S., von Hase, J., Cremer, C., Cremer, T., and Solovei, I. 2003. Three-dimensional arrangements of centromeres and telomeres in nuclei of human and murine lymphocytes. Chromosome Res. 11: 485-502.
64. Yao, Y.L., Yang, W.M., and Seto, E. 2001. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 21: 5979-5991.
65. Zhao, Y., Lu, J., Sun, H., Chen, X., Huang, W., Tao, D., and Huang, B. 2005. Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila. Biochem. Biophys. Res. Commun. 326: 811-816.